Madrid, Spain

Santiago Munne

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Madrid, ES (2021)
  • Barcelona, ES (2023)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Santiago Munne: Innovator in Microfluidic Technology

Introduction

Santiago Munne is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of microfluidics, particularly in the area of biological material handling and cryopreservation. With a total of 3 patents to his name, Munne is recognized for his innovative approaches to improving cell viability during critical processes.

Latest Patents

Munne's latest patents focus on microfluidic devices and methods for delivering solutions to biological materials. These inventions aim to create concentration gradients for biological materials such as oocytes and embryos, facilitating processes like cryopreparation, cryopreservation, and thawing. His work addresses the challenges associated with cryopreservation methods, such as vitrification, which utilize cryoprotectants to minimize the formation of damaging ice crystals in cells during freezing. The microfluidic devices and methods he has developed enhance cell viability and efficiency during the handling and cryopreservation of biological materials.

Career Highlights

Santiago Munne is currently associated with Overture Life, Inc., where he continues to advance his research and innovations in microfluidic technology. His work has garnered attention for its potential impact on reproductive biology and related fields.

Collaborations

Munne collaborates with notable colleagues, including Lionel Matthys and Joana Alexandra Sales Fidalgo, contributing to a dynamic research environment that fosters innovation.

Conclusion

Santiago Munne's contributions to microfluidic technology and cryopreservation are paving the way for advancements in biological material handling. His innovative patents reflect a commitment to improving cell viability and efficiency in critical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…